• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床前模型在放射性药物治疗中的作用。

The role of preclinical models in radiopharmaceutical therapy.

作者信息

Sgouros George, Hobbs Robert F, Abou Diane S

机构信息

From the Division of Nuclear Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, School of Medicine, Baltimore, MD.

出版信息

Am Soc Clin Oncol Educ Book. 2014:e121-5. doi: 10.14694/EdBook_AM.2014.34.e121.

DOI:10.14694/EdBook_AM.2014.34.e121
PMID:24857091
Abstract

Radiopharmaceutical therapy (RPT) is a treatment modality that involves the use of radioactively labeled targeting agents to deliver a cytotoxic dose of radiation to tumor while sparing normal tissue. The biologic function of the target and the biologic action of the targeting agent is largely irrelevant as long as the targeting agent delivers cytotoxic radiation to the tumor. Preclinical RPT studies use imaging and ex vivo evaluation of radioactivity concentration in target and normal tissues to obtain biodistribution and pharmacokinetic data that can be used to evaluate radiation absorbed doses. Since the efficacy and toxicity of RPT depend on radiation absorbed dose, this quantity can be used to translate results from preclinical studies to human studies. The absorbed dose can also be used to customize therapy to account for pharmacokinetic and other differences among patients so as to deliver a prespecified absorbed dose to the tumor or to dose-limiting tissue. The combination of RPT with other agents can be investigated and optimized by identifying the effect of other agents on tumor or normal tissue radiosensitivity and also on how other agents change the absorbed dose to these tissues. RPT is a distinct therapeutic modality whose mechanism of action is well understood. Measurements can be made in preclinical models to help guide clinical implementation of RPT and optimize combination therapy using RPT.

摘要

放射性药物治疗(RPT)是一种治疗方式,它涉及使用放射性标记的靶向剂,在 sparing正常组织的同时,向肿瘤输送细胞毒性剂量的辐射。只要靶向剂向肿瘤输送细胞毒性辐射,靶点的生物学功能和靶向剂的生物学作用在很大程度上是无关紧要的。临床前RPT研究使用成像和对靶点及正常组织中放射性浓度的体外评估,以获得可用于评估辐射吸收剂量的生物分布和药代动力学数据。由于RPT的疗效和毒性取决于辐射吸收剂量,这个量可用于将临床前研究结果转化为人体研究结果。吸收剂量还可用于定制治疗,以考虑患者之间的药代动力学和其他差异,从而向肿瘤或剂量限制组织输送预先指定的吸收剂量。通过确定其他药物对肿瘤或正常组织放射敏感性的影响,以及其他药物如何改变这些组织的吸收剂量,可以研究和优化RPT与其他药物的联合使用。RPT是一种独特的治疗方式,其作用机制已得到充分理解。可以在临床前模型中进行测量,以帮助指导RPT的临床实施,并优化使用RPT的联合治疗。

相似文献

1
The role of preclinical models in radiopharmaceutical therapy.临床前模型在放射性药物治疗中的作用。
Am Soc Clin Oncol Educ Book. 2014:e121-5. doi: 10.14694/EdBook_AM.2014.34.e121.
2
Dosimetry for radiopharmaceutical therapy.放射性药物治疗的剂量学。
Semin Nucl Med. 2014 May;44(3):172-8. doi: 10.1053/j.semnuclmed.2014.03.007.
3
Radiopharmaceutical therapy in the era of precision medicine.精准医学时代的放射性药物治疗。
Eur J Cancer. 2014 Sep;50(13):2360-3. doi: 10.1016/j.ejca.2014.04.025. Epub 2014 Jun 19.
4
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.肿瘤对放射性药物治疗的反应:已知与未知。
J Nucl Med. 2021 Dec;62(Suppl 3):12S-22S. doi: 10.2967/jnumed.121.262750.
5
A persistent belief in radiopharmaceutical therapy.对放射性药物治疗的持续信念。
Med Phys. 2023 Jun;50 Suppl 1:104-108. doi: 10.1002/mp.16272. Epub 2023 Feb 17.
6
MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.医学内照射剂量学第20号手册:模型假设对肾脏剂量测定及反应的影响——对放射性核素治疗的启示
J Nucl Med. 2008 Nov;49(11):1884-99. doi: 10.2967/jnumed.108.053173. Epub 2008 Oct 16.
7
The Case for Dosimetry in Alpha-Emitter Therapy.α粒子发射体治疗中的剂量测定理由
J Med Imaging Radiat Sci. 2019 Dec;50(4 Suppl 1):S45-S46. doi: 10.1016/j.jmir.2019.07.007. Epub 2019 Sep 16.
8
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab.(111)In-BzDTPA-帕妥珠单抗I/II期临床试验的临床试验申请监管批准所需的临床前药代动力学、生物分布、辐射剂量测定和急性毒性研究。
Nucl Med Biol. 2015 Feb;42(2):78-84. doi: 10.1016/j.nucmedbio.2014.09.011. Epub 2014 Oct 14.
9
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.癌症临床放射性药物治疗中的剂量测定:当前实践中的实用性与完美性
J Nucl Med. 2021 Dec;62(Suppl 3):60S-72S. doi: 10.2967/jnumed.121.262977.
10
Current Status of Radiopharmaceutical Therapy.放射性药物治疗的现状
Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):891-901. doi: 10.1016/j.ijrobp.2020.08.035. Epub 2020 Aug 14.

引用本文的文献

1
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories.面向精准放射性药物治疗的计算核肿瘤学:当前工具、技术及未知领域
J Nucl Med. 2025 Apr 1;66(4):509-515. doi: 10.2967/jnumed.124.267927.
2
Optimizing Cancer Treatment: Exploring the Role of AI in Radioimmunotherapy.优化癌症治疗:探索人工智能在放射免疫治疗中的作用。
Diagnostics (Basel). 2025 Feb 6;15(3):397. doi: 10.3390/diagnostics15030397.
3
Mathematic Modeling of Tumor Growth During [Lu]Lu-PSMA Therapy: Insights into Treatment Optimization.
[镥]镥-PSMA治疗期间肿瘤生长的数学建模:对治疗优化的见解
J Nucl Med. 2025 Jan 3;66(1):84-90. doi: 10.2967/jnumed.124.268457.
4
How to design a theranostic trial?如何设计一项治疗诊断试验?
Endocr Oncol. 2024 May 10;4(1):e230045. doi: 10.1530/EO-23-0045. eCollection 2024 Jan 1.
5
Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?当前的放射性药物开发的临床前策略能否满足靶向α治疗的需求?
Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):1965-1980. doi: 10.1007/s00259-024-06719-5. Epub 2024 Apr 27.
6
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation.放射性药物:探索精准医学与治疗创新的前沿。
Eur J Med Res. 2024 Jan 5;29(1):26. doi: 10.1186/s40001-023-01627-0.
7
Heterogeneity of absorbed dose distribution in kidney tissues and dose-response modelling of nephrotoxicity in radiopharmaceutical therapy with beta-particle emitters: A review.β粒子发射放射性药物治疗中肾组织内吸收剂量分布的异质性与肾毒性的剂量反应建模:综述。
Z Med Phys. 2024 Nov;34(4):491-509. doi: 10.1016/j.zemedi.2023.02.006. Epub 2023 Apr 6.
8
Current Status of Radiopharmaceutical Therapy.放射性药物治疗的现状
Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):891-901. doi: 10.1016/j.ijrobp.2020.08.035. Epub 2020 Aug 14.